Compare CVS Health Corp (CVS) vs Super Micro Computer Inc (SMCI) Price & Performance

CVS Health trades at $94.12, down 1.62% today, but maintains strong analyst support with 33 buy ratings and a $115.90 consensus price target. The company delivered three consecutive earnings beats in 2026, with Q2 EPS of $2.58 beating expectations by 38%. Technical indicators show mixed signals with bullish oscillators but bearish moving averages, while fundamentals reveal solid revenue growth to $402.07B in 2025 despite margin compression.

CVS presents a compelling value opportunity with attractive valuation ratios (P/S: 0.29, P/B: 1.5) and strong institutional confidence. Near-term catalysts include continued Aetna recovery and healthcare services expansion, though risks include 2027 PBM pressures and margin volatility. The stock offers 23% upside to analyst targets with defensive healthcare positioning.

Super Micro Computer (SMCI) trades at $36.75, up 16.85% on strong Q4 2026 earnings, beating EPS estimates with $1.70 actual versus $0.92 expected. The stock shows bullish technical signals with moving averages supporting upward momentum, while RSI indicates potential overbought conditions. Revenue surged 93% year-over-year to $11.1 billion in Q4, though slightly below the $11.6 billion consensus, with robust FY2027 guidance of $65–72 billion revenue highlighting AI-driven demand.

Outlook remains positive due to AI infrastructure growth and earnings beats, but risks include supply chain delays and high valuation multiples. Analysts maintain a $40.40 consensus target with 36% buy ratings. Investors should weigh strong cash flow and margin expansion against competitive pressures and macroeconomic volatility.